{
    "id": "0955",
    "question": "A 59-year-old woman presents to the outpatient clinic for worsening symptoms of congestive heart failure. She states that while she used to be able to go for short walks, she is no longer able to do so. Now, even simple tasks like getting ready in the morning have become burdensome for her. When she gets tired, sitting down helps to alleviate her symptoms. Her blood pressure is 136/92 mm Hg and heart rate is 76/min. On physical examination, she has regular heart sounds but does have 1+ pitting edema to her bilateral lower extremities. What is her New York Heart Association Functional Classification for congestive heart failure?",
    "options": {
        "A": " New York Heart Association Class IIa",
        "B": "New York Heart Association Class IIb",
        "C": "New York Heart Association Class III",
        "D": "New York Heart Association Class IV"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"To determine the New York Heart Association (NYHA) Functional Classification for congestive heart failure, we need to analyze the patient's symptoms and physical examination findings. The patient reports that she is no longer able to perform short walks and even simple tasks like getting ready in the morning have become burdensome, indicating a significant limitation in physical activity. She also experiences relief from symptoms when sitting down, which suggests orthopnea. Additionally, the presence of 1+ pitting edema to her bilateral lower extremities indicates fluid overload. Based on these findings, we can classify the patient's heart failure severity as follows: * Class I: No limitation of physical activity, symptoms only with greater than ordinary exercise * Class II: Slight limitation of physical activity, fatigue, palpitations, dyspnea, or anginal pain with ordinary physical activity * Class III: Marked limitation of physical activity, fatigue, shortness of breath, and tachycardia with less than ordinary physical activity, but no symptoms at rest * Class IV: Symptoms even when the patient is at rest Considering the patient's symptoms and physical examination findings, she is able to perform ordinary activities without symptoms, but has slight limitation of physical activity due to fatigue, palpitations, dyspnea, or anginal pain with ordinary physical activity. This aligns with the definition of NYHA Class IIa. However, the patient's symptoms are not completely relieved with ordinary physical activity, but rather with sitting down, which is more consistent with Class IIb. Class IIb is characterized by fatigue, palpitations, dyspnea, or anginal pain with ordinary physical activity, and symptoms that are not completely relieved with ordinary physical activity. Therefore, the most appropriate classification for this patient would be NYHA Class IIb.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_1130",
            "title": "Pharmacology_Katzung",
            "content": "Irbesartan Generic,Avapro Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD* A 56-year-old woman presents in the office with a history of recent-onset chest discomfort when jogging or swimming vigorously. The pain is dull but poorly localized; it disap-pears after 5\u201310 minutes of rest. She has never smoked but has a history of hyperlipidemia (total cholesterol level of 245 mg/dL and low-density lipoprotein [LDL] of 160 mg/dL recorded 1 year ago) and admits that she has not been fol-lowing the recommended diet. Her father survived a \u201cheart attack\u201d at age 55, and an uncle died of some cardiac disease at age 60. On physical examination, the patient\u2019s blood pressure is 145/90 mm Hg, and her heart rate is 80 bpm. She is in no acute distress, and there are no other significant physical findings; an electrocardiogram is normal except for slight left ventricular hypertrophy. Assuming that a diagno-sis of stable effort angina is correct, what medical treatment should be implemented?"
        },
        {
            "id": "InternalMed_Harrison_19080",
            "title": "InternalMed_Harrison",
            "content": "Exertional angina typically is relieved in 1\u20135 min by slowing or ceasing activities and even more rapidly by rest and sublingual nitroglycerin (see below). Indeed, the diagnosis of angina should be suspect if it does not respond to the combination of these measures. The severity of angina can be conveniently summarized by the Canadian Cardiac Society functional classification (Table 293-1). Its impact on the patient\u2019s functional capacity can be described by using the New York Heart Association functional classification (Table 293-1). I Patients have cardiac disease but without the resulting limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain. II Patients have cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain."
        },
        {
            "id": "Pharmacology_Katzung_1243",
            "title": "Pharmacology_Katzung",
            "content": "Tadalafil Cialis, Adcirca Cilostazol Generic, Pletal Pentoxifylline Generic, Trental Bertram G. Katzung, MD, PhD* A 55-year-old man noticed shortness of breath with exer-tion while on a camping vacation in a national park. He has a 15-year history of poorly controlled hypertension. The shortness of breath was accompanied by onset of swelling of the feet and ankles and increasing fatigue. On physical examination in the clinic, he is found to be mildly short of breath lying down but feels better sitting upright. Pulse is 100 bpm and regular, and blood pressure is 165/100 mm Hg. Crackles are noted at both lung bases, and his jugular venous pressure is elevated. The liver is enlarged, and there is 3+ edema of the ankles and feet. An echocardiogram shows an enlarged, poorly contracting heart with a left ven-tricular ejection fraction of about 30% (normal: 60%). The presumptive diagnosis is stage C, class III heart failure with reduced ejection fraction. What treatment is indicated?"
        },
        {
            "id": "InternalMed_Harrison_3641",
            "title": "InternalMed_Harrison",
            "content": "A 76-year-old woman presented with a several-month history of diarrhea, with marked worsening over the 2\u20133 weeks before admission (up to 12 stools a day). Review of systems was negative for fever, orthostatic dizziness, nausea and vomiting, or headache. Past medical history included hypertension, kidney stones, and hypercholesterolemia; medications included atenolol, spironolactone, and lovastatin. She also reliably consumed >2 L of liquid per day in management of the nephrolithiasis. The patient received 1 L of saline over the first 5 h of her hospital admission. On examination at hour 6, the heart rate was 72 sitting and 90 standing, and blood pressure was 105/50 mmHg lying and standing. Her jugular venous pressure (JVP) was indistinct with no peripheral edema. On abdominal examination, the patient had a slight increase in bowel sounds but a nontender abdomen and no organomegaly."
        },
        {
            "id": "InternalMed_Harrison_18177",
            "title": "InternalMed_Harrison",
            "content": "Class III Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain. Class IV Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased. Source: Adapted from New York Heart Association, Inc., Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis, 6th ed. Boston, Little Brown, 1964, p. 114."
        },
        {
            "id": "Surgery_Schwartz_5347",
            "title": "Surgery_Schwartz",
            "content": "regard to heart failure, functional capacity is strongly correlated with mortality. The New York Heart Association (NYHA) functional class is a widely used classification system in categorizing patients based on their functional status (Table 21-1).3 The NYHA clas-sification has become one basis by which to compare patient populations in many studies. Although less commonly used, the Canadian Cardiovascular Society (CCS) angina classification is also used to incorporate anginal symptoms into the functional assessment for prognostic value (Table 21-2).Physical ExaminationThe physical examination is an invaluable tool in directing further diagnostic studies in the management of a patient with suspected heart disease. The astute clinician may be able to detect subtle signs that may further characterize the underlying pathology.The general appearance of a patient is important in the clinical assessment. A pale, diaphoretic, and obviously uncom-fortable patient is more likely to be in a"
        },
        {
            "id": "Obstentrics_Williams_6691",
            "title": "Obstentrics_Williams",
            "content": "\u2022 Classification of Functional Heart Disease No clinically applicable test accurately measures functional cardiac capacity. The clinical classification of the New York Heart Association (NYHA) is based on past and present disability and is uninfluenced by physical signs: \u2022 Class I. Uncompromised-no limitation of physical activiy: These women do not have symptoms of cardiac insuiciency or experience anginal pain. Class II. Slight limitation of physical activiy: These women are comfortable at rest, but if ordinary physical activity is undertaken, discomfort in the form of excessive fatigue, palpitation, dyspnea, or anginal pain results. Class III. Marked limitation of physical activiy: These women are comfortable at rest, but less than ordinary activity causes excessive fatigue, palpitation, dyspnea, or anginal pain."
        },
        {
            "id": "InternalMed_Harrison_17257",
            "title": "InternalMed_Harrison",
            "content": "consideration of the patient\u2019s therapeutic regimen. For example, the persistence or development of edema, breathlessness, and other manifestations of heart failure in a patient who is receiving optimal doses of diuretics and other therapies for heart failure (Chap. 279) is far graver than are similar manifestations in the absence of treatment. Similarly, the presence of angina pectoris despite treatment with optimal doses of multiple antianginal drugs (Chap. 293) is more serious than it is in a patient on no therapy. In an effort to determine the progression of symptoms, and thus the severity of the underlying illness, it may be useful to ascertain what, if any, specific tasks the patient could have carried out 6 months or 1 year earlier that he or she cannot carry out at present."
        },
        {
            "id": "Pharmacology_Katzung_1304",
            "title": "Pharmacology_Katzung",
            "content": "Once stage C is reached, the severity of heart failure is usually described according to a scale devised by the New York Heart Association. Class I failure is associated with no limitations on ordinary activities and symptoms that occur only with greater than ordinary exercise. Class II failure is characterized by slight limitation of activities and results in fatigue and palpitations with ordinary physical activity. Class III failure results in fatigue, shortness of breath, and tachycardia with less than ordinary physical activity, but no symptoms at rest. Class IV failure is associated with symptoms even when the patient is at rest."
        },
        {
            "id": "InternalMed_Harrison_17659",
            "title": "InternalMed_Harrison",
            "content": "courtesy of Dr. James Min, Cornell University, New York.) (2) What are the shortand long-term risks? (3) Does the patient need to be considered for revascularization? For symptomatic patients without a prior history of CAD and a normal or nearly normal resting ECG who are able to exercise, the American Colloge of Cardiology/American Heart Association guidelines recommend standard exercise treadmill testing (ETT) as the initial testing strategy. The guidelines further suggest that patients who are categorized as low risk by ETT (e.g., those achieving >10 metabolic equivalents [METS] without chest pain or ECG changes) be treated initially with medical therapy, and those with high-risk ETT findings (i.e., typical angina with >2 mm ST-segment depression in multiple leads, ST elevation during exercise, drop in blood pressure, or sustained ventricular arrhtyhmias) be referred for coronary angiography."
        },
        {
            "id": "InternalMed_Harrison_18179",
            "title": "InternalMed_Harrison",
            "content": "Despite many recent advances in the evaluation and management of HF, the development of symptomatic HF still carries a poor prognosis. Community-based studies indicate that 30\u201340% of patients die within 1 year of diagnosis and 60\u201370% die within 5 years, mainly from worsening HF or as a sudden event (probably because of a ventricular arrhythmia). Although it is difficult to predict prognosis in an individual, patients with symptoms at rest (New York Heart Association [NYHA] class IV) have a 30\u201370% annual mortality rate, whereas patients with symptoms with moderate activity (NYHA class II) have an annual mortality rate of 5\u201310%. Thus, functional status is an important predictor of patient outcome (Table 279-2)."
        },
        {
            "id": "First_Aid_Step2_25",
            "title": "First_Aid_Step2",
            "content": "The most common cause of right-sided heart failure is left-sided heart failure. Diuretics are for symptomatic relief only and confer no mortality benef t. Heart failure caused by systolic dysfunction is defined as a \u2193 EF (< 50%) and left ventricular end-diastolic volumes. It is caused by inadequate left ventricular contractility or \u2191 afterload. The heart compensates for low EF and preload through hypertrophy and ventricular dilation (Frank-Starling law), but the compensation ultimately fails, leading to \u2191 myocardial work and worsening systolic function. Exertional dyspnea is the earliest and most common presenting symptom and progresses to orthopnea, paroxysmal nocturnal dyspnea (PND), and finally rest dyspnea. Chronic cough, fatigue, lower extremity edema, nocturia, Cheyne-Stokes respirations, and/or abdominal fullness may be seen. Look for signs to distinguish leftfrom right-sided heart failure (see Table 2.1-6)."
        },
        {
            "id": "Pharmacology_Katzung_2257",
            "title": "Pharmacology_Katzung",
            "content": "Anthony J. Trevor, PhD not overweight, and she takes no prescription drugs. She drinks decaffeinated coffee but only one cup in the morning; however, she drinks as many as six cans per day of diet cola. She drinks a glass of wine with her evening meal but does not like stronger spirits. What other aspects of this patient\u2019s history would you like to know? What therapeutic measures are appropriate for this patient? What drug, or drugs, (if any) would you prescribe? At her annual physical examination, a 53-year-old middle school teacher complains that she has been having difficulty falling asleep, and after falling asleep, she awakens several times during the night. These episodes now occur almost nightly and are interfering with her ability to teach. She has tried various over-the-counter sleep remedies, but they were of little help and she experienced \u201changover\u201d effects on the day following their use. Her general health is good, she is"
        },
        {
            "id": "Pharmacology_Katzung_3234",
            "title": "Pharmacology_Katzung",
            "content": "What CYP450 and pharmacodynamic interactions might be associated with fluoxetine use in this patient? Which class of antidepressants would be contraindicated in this patient? A 47-year-old woman presents to her primary care physician with a chief complaint of fatigue. She indicates that she was promoted to senior manager in her company approximately 11 months earlier. Although her promotion was welcome and came with a sizable raise in pay, it resulted in her having to move away from an office and group of colleagues she very much enjoyed. In addition, her level of responsibility increased dramatically. The patient reports that for the last 7 weeks, she has been waking up at 3 am every night and been unable to go back to sleep. She dreads the day and the stresses of the workplace. As a consequence, she is not eating as well as she might and has dropped 7% of her body weight in the last 3 months. She also reports being so stressed that she breaks down crying in the office occasionally"
        },
        {
            "id": "InternalMed_Harrison_18581",
            "title": "InternalMed_Harrison",
            "content": "Patients with chronic mild-to-moderate, isolated MR are usually asymptomatic. This form of LV volume overload is well tolerated. Fatigue, exertional dyspnea, and orthopnea are the most prominent complaints in patients with chronic severe MR. Palpitations are common and may signify the onset of AF. Right-sided heart failure, with painful hepatic congestion, ankle edema, distended neck veins, ascites, and secondary TR, occurs in patients with MR who have associated pulmonary vascular disease and pulmonary hypertension. Acute pulmonary edema is common in patients with acute severe MR. In patients with chronic severe MR, the arterial pressure is usually normal, although the carotid arterial pulse may show a sharp, low-volume upstroke owing to the reduced forward CO. A systolic thrill is often palpable at the cardiac apex, the LV is hyperdynamic with a brisk systolic impulse and a palpable rapid-filling wave (S3), and the apex beat is often displaced laterally."
        },
        {
            "id": "InternalMed_Harrison_18170",
            "title": "InternalMed_Harrison",
            "content": "Heart Failure: Pathophysiology and Diagnosis Douglas L. Mann, Murali Chakinala HEART FAILURE DEFINITION 279 SEC Tion 4 Despite repeated attempts to develop a mechanistic definition that encompasses the heterogeneity and complexity of heart failure (HF), no single conceptual paradigm has withstood the test of time. The current American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guidelines define HF as a complex clinical syndrome that results from structural or functional impairment of ventricular filling or ejection of blood, which in turn leads to the cardinal clinical symptoms of dyspnea and fatigue and signs of HF, namely edema and rales. Because many patients present without signs or symptoms of volume overload, the term \u201cheart failure\u201d is preferred over the older term \u201ccongestive heart failure.\u201d"
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Pharmacology_Katzung_4230",
            "title": "Pharmacology_Katzung",
            "content": "JP is a 33-year-old woman who presents with complaints of fatigue requiring daytime naps, weight gain, cold intoler-ance, and muscle weakness for the last few months. These complaints are new since she used to always feel \u201chot,\u201d noted difficulty sleeping, and could eat anything that she wanted without gaining weight. She also would like to become preg-nant in the near future. Because of poor medication adherence to methimazole and propranolol, she received radioactive iodine (RAI) therapy, developed hypothyroidism, and was started on levothyroxine 100 mcg daily. Other medications include calcium carbonate three times daily to \u201cprotect her bones\u201d and omeprazole for \u201cheartburn.\u201d On physical exami-nation, her blood pressure is 130/89 mm Hg with a pulse of 50 bpm. Her weight is 136 lb (61.8 kg), an increase of 10 lb (4.5 kg) in the last year. Her thyroid gland is not palpable and her reflexes are delayed. Laboratory findings include a thyroid-stimulating hormone (TSH) level of 24.9 \u03bcIU/mL"
        },
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "Biochemistry_Lippincott_1914",
            "title": "Biochemistry_Lippinco",
            "content": "Patient Presentation: BE is a 45-year-old woman who presents with concerns about sudden (paroxysmal), intense, brief episodes of headache, sweating (diaphoresis), and a racing heart (palpitations). Focused History: BE reports that the attacks started ~3 weeks ago. They last from 2 to 10 minutes, during which time she feels quite anxious. During the attacks, it feels as though her heart is skipping beats (arrhythmia). At first, she thought the attacks were related to recent stress at work and maybe even menopause. The last time it happened, she was in a pharmacy and had her blood pressure taken. She was told it was 165/110 mm Hg. BE notes that she has lost weight (~8 lbs) in this period even though her appetite has been good."
        },
        {
            "id": "Pharmacology_Katzung_1335",
            "title": "Pharmacology_Katzung",
            "content": "A 69-year-old retired teacher presents with a 1-month history of palpitations, intermittent shortness of breath, and fatigue. She has a history of hypertension. An electrocardiogram (ECG) shows atrial fibrillation with a ventricular response of 122 beats/min (bpm) and signs of left ventricular hypertrophy. She is anticoagulated with warfarin and started on sustained-release metoprolol, 50 mg/d. After 7 days, her rhythm reverts to normal sinus rhythm spontaneously. However, over the ensuing month, she continues to have intermittent palpita-tions and fatigue. Continuous ECG recording over a 48-hour period documents paroxysms of atrial fibrillation with heart rates of 88\u2013114 bpm. An echocardiogram shows a left ven-tricular ejection fraction of 38% (normal \u2265 60%) with no localized wall motion abnormality. At this stage, would you initiate treatment with an antiarrhythmic drug to maintain normal sinus rhythm, and if so, what drug would you choose?"
        },
        {
            "id": "InternalMed_Harrison_18683",
            "title": "InternalMed_Harrison",
            "content": "For all cardiomyopathies, the early symptoms often relate to exertional intolerance with breathlessness or fatigue, usually from inadequate cardiac reserve during exercise. These symptoms may initially go unnoticed or be attributed to other causes, commonly lung disease or age-dependent exercise limitation. As fluid retention leads to elevation of resting filling pressures, shortness of breath may occur during routine daily activity such as dressing and may manifest as dyspnea or cough when lying down at night. Although often considered the hallmark of congestion, peripheral edema may be absent despite severe fluid retention, particularly in younger patients in whom ascites and abdominal discomfort may dominate. The nonspecific term congestive heart failure describes only the resulting syndrome of fluid retention, which is common to all three types of cardiomyopathy and also to cardiac structural diseases associated 1From BJ Maron et al: Circulation 113:1807, 2006."
        },
        {
            "id": "Pharmacology_Katzung_6809",
            "title": "Pharmacology_Katzung",
            "content": "A 21-year-old woman comes with her parents to discuss therapeutic options for her Crohn\u2019s disease. She was diag-nosed with Crohn\u2019s disease 2 years ago, and it involves her terminal ileum and proximal colon, as confirmed by colonoscopy and small bowel radiography. She was initially treated with mesalamine and budesonide with good response, but over the last 2 months, she has had a relapse of her symptoms. She is experiencing fatigue, cramping, abdominal pains, and nonbloody diarrhea up to 10 times daily, and she has had a 15-lb weight loss. She has no other significant medical or surgical his-tory. Her current medications are mesalamine 2.4 g/d and budesonide 9 mg/d. She appears thin and tired. Abdominal examination reveals tenderness without guarding in the right lower quadrant; no masses are palpable. On perianal examination, there is no tenderness, fissure, or fistula. Her laboratory data are notable for anemia and elevated C-reactive protein. What are the options for immediate"
        },
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "InternalMed_Harrison_18546",
            "title": "InternalMed_Harrison",
            "content": "rapid sit-ups) carried out just before auscultation. In general, the duration of this murmur correlates with the severity of the stenosis in patients with preserved CO. In patients with sinus rhythm, the murmur often reappears or becomes louder during atrial systole (presystolic accentuation). Soft, grade I or II/VI systolic murmurs are commonly heard at the apex or along the left sternal border in patients with pure MS and do not necessarily signify the presence of MR. Hepatomegaly, ankle edema, ascites, and pleural effusion, particularly in the right pleural cavity, may occur in patients with MS and RV failure."
        },
        {
            "id": "InternalMed_Harrison_2759",
            "title": "InternalMed_Harrison",
            "content": "If diagnosis still uncertain, obtain cardiopulmonary exercise test FIGuRE 47e-2 Algorithm for the evaluation of the patient with dyspnea. JVP, jugular venous pulse; CHF, congestive heart failure; ECG, electrocardiogram; CT, computed tomography. (Adapted from RM Schwartzstein, D Feller-Kopman, in E Braunwald, L Goldman [eds]. Primary Cardiology, 2nd ed. Philadelphia, WB Saunders, 2003.) Patients with exertional dyspnea should be asked to walk under observation in order to reproduce the symptoms. The patient should be examined during and at the end of exercise for new findings that were not present at rest and for changes in oxygen saturation."
        },
        {
            "id": "Pharmacology_Katzung_1897",
            "title": "Pharmacology_Katzung",
            "content": "The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds John Hwa, MD, PhD, & Kathleen Martin, PhD* pulmonary pressures, and right ventricular enlargement. Cardiac catheterization confirmed the severely elevated pulmonary pressures. She was commenced on appropri-ate therapies. Which of the eicosanoid agonists have been demonstrated to reduce both morbidity and mortality in patients with such a diagnosis? What are the modes of action? A 40-year-old woman presented to her doctor with a 6-month history of increasing shortness of breath. This was associated with poor appetite and ankle swell-ing. On physical examination, she had elevated jugular venous distention, a soft tricuspid regurgitation murmur, clear lungs, and mild peripheral edema. An echocardio-gram revealed tricuspid regurgitation, severely elevated"
        },
        {
            "id": "InternalMed_Harrison_18507",
            "title": "InternalMed_Harrison",
            "content": "Chronic severe AR may have a long latent period, and patients may remain relatively asymptomatic for as long as 10\u201315 years. However, uncomfortable awareness of the heartbeat, especially on lying down, may be an early complaint. Sinus tachycardia, during exertion or with emotion, or premature ventricular contractions may produce particularly uncomfortable palpitations as well as head pounding. These complaints may persist for many years before the development of exertional dyspnea, usually the first symptom of diminished cardiac reserve. The dyspnea is followed by orthopnea, paroxysmal nocturnal dyspnea, and excessive diaphoresis. Anginal chest pain even in the absence of CAD may occur in patients with severe AR, even in younger patients. Anginal pain may develop at rest as well as during exertion. Nocturnal angina may be a particularly troublesome symptom, and it may be accompanied by marked diaphoresis. The anginal episodes can be prolonged and often do not respond satisfactorily to"
        },
        {
            "id": "First_Aid_Step2_38",
            "title": "First_Aid_Step2",
            "content": "Signs and symptoms of left-sided and right-sided heart failure occur, but symptoms of right-sided heart failure (JVD, peripheral edema) often predominate. CXR, MRI, and cardiac catheterization may be helpful, but echocardiography is key to diagnosis and reveals rapid early filling with a normal or near-normal EF. Cardiac biopsy may reveal fibrosis or evidence of infiltration. ECG frequently shows LBBB. Therapeutic options are limited and generally are palliative only. Medical treatment includes cautious use of diuretics for \ufb02uid overload, vasodilators to \u2193 filling pressure, and anticoagulation if not contraindicated. Major risk factors for CAD include age, male gender, hyperlipidemia, DM, hypertension, obesity, a family history, and smoking. The classic triad of angina consists of substernal chest pain that is provoked by exertion and relieved by rest or nitrates."
        },
        {
            "id": "InternalMed_Harrison_19094",
            "title": "InternalMed_Harrison",
            "content": "Electrocardiographic The most widely used test for both the diagnosis of IHD and the estimation of risk and prognosis involves recording the 12-lead ECG before, during, and after exercise, usually on a treadmill (Fig. 293-2). The test consists of a standardized incremental increase in external workload (Table 293-2) while symptoms, the ECG, and arm blood pressure are monitored. Exercise duration is usually symptom-limited, and the test is discontinued upon evidence of chest discomfort, severe shortness of breath, dizziness, severe fatigue, ST-segment depression >0.2 mV (2 mm), a fall in systolic blood pressure >10 mmHg, or the development of a ventricular tachyarrhythmia. This test is used to discover any limitation in exercise performance, detect typical ECG signs of myocardial ischemia, and establish their relationship to chest discomfort. The ischemic ST-segment response generally is defined as flat or downsloping depression of the ST segment >0.1 mV below baseline (i.e., the PR"
        },
        {
            "id": "InternalMed_Harrison_17245",
            "title": "InternalMed_Harrison",
            "content": "The symptoms caused by heart disease result most commonly from myocardial ischemia, disturbance of the contraction and/or relaxation of the myocardium, obstruction to blood flow, or an abnormal cardiac rhythm or rate. Ischemia, which is caused by an imbalance between the heart\u2019s oxygen supply and demand, is manifest most frequently as chest discomfort (Chap. 19), whereas reduction of the pumping ability of the heart commonly leads to fatigue and elevated intravascular pressure upstream of the failing ventricle. The latter results in abnormal fluid accumulation, with peripheral edema (Chap. 50) or pulmonary congestion and dyspnea (Chap. 47e). Obstruction to blood flow, as occurs in valvular stenosis, can cause symptoms resembling those of myocardial failure (Chap. 279). Cardiac arrhythmias often develop suddenly, and the resulting symptoms and signs\u2014palpitations (Chap. 52), dyspnea, hypotension, and syncope (Chap. 27)\u2014generally occur abruptly and may disappear as rapidly as they"
        },
        {
            "id": "Surgery_Schwartz_5514",
            "title": "Surgery_Schwartz",
            "content": "before the end of diastole, the diastolic murmur of AI may be short and/or soft. The reduced systolic pressure may attenuate the increase in peripheral pulse pressure seen in chronic AI, and early closing of the mitral valve due to elevated left ventricular end-diastolic pressures may diminish the intensity of the first heart sound in the acute setting.In patients with chronic AI, symptoms of heart fail-ure and myocardial ischemia develop after the compensatory phase.2 Patients gradually begin to complain of exertional dys-pnea, fatigue, orthopnea, and paroxysmal nocturnal dyspnea, often after significant myocardial dysfunction has developed. Angina is a common complaint late in the course, especially during sleep when heart rate slows and arterial diastolic pres-sure falls. Patients also may experience exertional angina secondary to diminished coronary perfusion in the setting of myocardial hypertrophy. Occasionally, the compensatory tachy-cardia that develops with chronic AI will"
        }
    ],
    "scores": [
        0.027004181740630052,
        0.02469528351881293,
        0.02433100452902433,
        0.023178752703075574,
        0.02290914396177554,
        0.0224469310702757,
        0.021680342218854752,
        0.0212499457543505,
        0.021016249684511247,
        0.020105501068546982,
        0.019991261074566627,
        0.01951265943270512,
        0.019142700128228614,
        0.018874643874643875,
        0.018691588785046728,
        0.018530750858337067,
        0.018433571185864764,
        0.018283519786274835,
        0.018265221017514596,
        0.018000642880102863,
        0.017973200673995025,
        0.01770873786407767,
        0.01748358528019545,
        0.01730769230769231,
        0.017157397310069065,
        0.01694915254237288,
        0.016783216783216783,
        0.016736694677871148,
        0.016718054128126072,
        0.016636998493769685,
        0.016285153695225638,
        0.01592157842157842
    ]
}